The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization

Amir Steinberg, Janet H. Van Cleave, Anish B. Parikh, Erin Moshier, Meng Ru, Douglas Marks, Antoinette Montelibano, Amanda Philpott, Kourtney Garner, Marilyn J. Hammer

Research output: Contribution to journalArticle

Abstract

Background: Abnormal blood glucose (BG) levels during hematopoietic cell transplantation (HCT) are associated with increased infections, delayed engraftment, and prolonged hospitalization, though little is known about these associations. Materials and Methods: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Results: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Conclusion: Pre-HCT BG trends may be a prognostic biomarker for adverse outcomes, and thus can help improve quality of care for HCT patients.

Original languageEnglish (US)
Pages (from-to)122-131
Number of pages10
JournalInternational Journal of Hematology-Oncology and Stem Cell Research
Volume13
Issue number3
DOIs
StatePublished - Jul 1 2019

Fingerprint

Health Resources
Cell Transplantation
Blood Glucose
Transplants
Glucose
Length of Stay
Pneumonia
Fever
Infection
Quality of Health Care
Hospitalization
Biomarkers

Keywords

  • Bone marrow transplant
  • Glucose
  • Health resource utilization
  • Hyperglycemia
  • Infection
  • Patient readmission

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Transplantation

Cite this

The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization. / Steinberg, Amir; Van Cleave, Janet H.; Parikh, Anish B.; Moshier, Erin; Ru, Meng; Marks, Douglas; Montelibano, Antoinette; Philpott, Amanda; Garner, Kourtney; Hammer, Marilyn J.

In: International Journal of Hematology-Oncology and Stem Cell Research, Vol. 13, No. 3, 01.07.2019, p. 122-131.

Research output: Contribution to journalArticle

Steinberg, Amir ; Van Cleave, Janet H. ; Parikh, Anish B. ; Moshier, Erin ; Ru, Meng ; Marks, Douglas ; Montelibano, Antoinette ; Philpott, Amanda ; Garner, Kourtney ; Hammer, Marilyn J. / The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization. In: International Journal of Hematology-Oncology and Stem Cell Research. 2019 ; Vol. 13, No. 3. pp. 122-131.
@article{fcae3202096549c4b5bc90fb18160fec,
title = "The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization",
abstract = "Background: Abnormal blood glucose (BG) levels during hematopoietic cell transplantation (HCT) are associated with increased infections, delayed engraftment, and prolonged hospitalization, though little is known about these associations. Materials and Methods: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Results: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Conclusion: Pre-HCT BG trends may be a prognostic biomarker for adverse outcomes, and thus can help improve quality of care for HCT patients.",
keywords = "Bone marrow transplant, Glucose, Health resource utilization, Hyperglycemia, Infection, Patient readmission",
author = "Amir Steinberg and {Van Cleave}, {Janet H.} and Parikh, {Anish B.} and Erin Moshier and Meng Ru and Douglas Marks and Antoinette Montelibano and Amanda Philpott and Kourtney Garner and Hammer, {Marilyn J.}",
year = "2019",
month = "7",
day = "1",
doi = "10.18502/ijhoscr.v13i3.1270",
language = "English (US)",
volume = "13",
pages = "122--131",
journal = "International Journal of Hematology-Oncology and Stem Cell Research",
issn = "1735-1243",
publisher = "Tehran University of Medical Sciences",
number = "3",

}

TY - JOUR

T1 - The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization

AU - Steinberg, Amir

AU - Van Cleave, Janet H.

AU - Parikh, Anish B.

AU - Moshier, Erin

AU - Ru, Meng

AU - Marks, Douglas

AU - Montelibano, Antoinette

AU - Philpott, Amanda

AU - Garner, Kourtney

AU - Hammer, Marilyn J.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background: Abnormal blood glucose (BG) levels during hematopoietic cell transplantation (HCT) are associated with increased infections, delayed engraftment, and prolonged hospitalization, though little is known about these associations. Materials and Methods: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Results: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Conclusion: Pre-HCT BG trends may be a prognostic biomarker for adverse outcomes, and thus can help improve quality of care for HCT patients.

AB - Background: Abnormal blood glucose (BG) levels during hematopoietic cell transplantation (HCT) are associated with increased infections, delayed engraftment, and prolonged hospitalization, though little is known about these associations. Materials and Methods: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Results: We retrospectively evaluated mean BG levels in the week prior to HCT and subsequent outcomes for 852 HCTs at our hospital from 1/2009 � 12/2013 pertaining to 745 patients. Outcomes included infections (pneumonia, C. difficile, positive cultures, administration of antimicrobials, or neutropenic fever), time-to-engraftment (TTE), and quality indicators (30- and 90-day readmission rates [RR] and median length-of-stay [LOS]). Conclusion: Pre-HCT BG trends may be a prognostic biomarker for adverse outcomes, and thus can help improve quality of care for HCT patients.

KW - Bone marrow transplant

KW - Glucose

KW - Health resource utilization

KW - Hyperglycemia

KW - Infection

KW - Patient readmission

UR - http://www.scopus.com/inward/record.url?scp=85071857563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071857563&partnerID=8YFLogxK

U2 - 10.18502/ijhoscr.v13i3.1270

DO - 10.18502/ijhoscr.v13i3.1270

M3 - Article

AN - SCOPUS:85071857563

VL - 13

SP - 122

EP - 131

JO - International Journal of Hematology-Oncology and Stem Cell Research

JF - International Journal of Hematology-Oncology and Stem Cell Research

SN - 1735-1243

IS - 3

ER -